	US 11,744,787 B2
	Menthol-containing aroma preparations
Sven Siegel, Höxter (DE); Arnold Machinek, Holzminden (DE); and Benoit Join, Holzminden (DE)
Assigned to Symrise AG, Holxminden (DE)
Appl. No. 16/301,233
Filed by Symrise AG, Holxminden (DE); and Sven Siegel, Höxter (DE)
PCT Filed May 14, 2016, PCT No. PCT/EP2016/060932 § 371(c)(1), (2) Date Nov. 13, 2018, PCT Pub. No. WO2017/198284, PCT Pub. Date Nov. 23, 2017.
Prior Publication US 2019/0282477 A1, Sep. 19, 2019
Int. Cl. A61K 8/37 (2006.01); A61K 31/05 (2006.01); A61K 31/222 (2006.01); A61K 8/34 (2006.01); A61K 9/68 (2006.01); A61K 31/085 (2006.01); A61Q 11/00 (2006.01); A61K 31/045 (2006.01)

CPC A61K 8/37 (2013.01) [A61K 8/34 (2013.01); A61K 8/347 (2013.01); A61K 9/0058 (2013.01); A61K 31/045 (2013.01); A61K 31/05 (2013.01); A61K 31/085 (2013.01); A61K 31/222 (2013.01); A61Q 11/00 (2013.01)]

7 Claims

1. A preparation for oral ingestion, comprising at least one aroma preparation comprising:

(a) a compound selected from eugenol, an essential oil containing eugenol, and a combination of eugenol and an essential oil containing eugenol; and

(b) a mixture of menthol and menthyl acetate at a weight ratio of 80:20 to 20:80 menthol to menthyl acetate,

wherein components (a) and (b) are present in a weight ratio of from 80:20 to 99:1.